Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avinger, Inc. - Common Stock (NQ:AVGR)

0.4740 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avinger, Inc. - Common Stock

< Previous 1 2 3 Next >
Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device
Via ACCESSWIRE
Avinger Reports First Quarter 2023 Results
Via ACCESSWIRE
Avinger to Announce First Quarter 2023 Results on May 10
Via ACCESSWIRE
Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium
Via ACCESSWIRE
Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
Via ACCESSWIRE
Avinger Announces 510(k) Filing of Pantheris LV
Via ACCESSWIRE
Avinger Reports Fourth Quarter 2022 Results
Via ACCESSWIRE
Avinger to Announce Fourth Quarter 2022 Results on March 15
Via ACCESSWIRE
Avinger Reports Third Quarter 2022 Results
Via ACCESSWIRE
Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices
Via ACCESSWIRE
Avinger to Announce Third Quarter 2022 Results on November 9
Via ACCESSWIRE
Avinger to Present at LD Micro Investor Conference
Via ACCESSWIRE
Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022
Via ACCESSWIRE
Avinger Reports Second Quarter 2022 Results
Via ACCESSWIRE
Avinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market Under Nasdaq Rules
Via ACCESSWIRE
Avinger to Announce Second Quarter 2022 Results on August 11
Via ACCESSWIRE
Avinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
Via ACCESSWIRE
Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Expands International Presence with First Commercial Shipment to Chile
REDWOOD CITY, CA / ACCESSWIRE / June 21, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
REDWOOD CITY, CA / ACCESSWIRE / June 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany
REDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Reports First Quarter 2022 Results
REDWOOD CITY, CA / ACCESSWIRE / May 10, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,... 
From Avinger, Inc.
Via AccessWire
Avinger to Announce First Quarter 2022 Results on May 10
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Avinger, Inc.
Via AccessWire
Avinger Announces Full Commercial Launch of Lightbox 3
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Issuance of Three New U.S. Patents in March 2022
16 New U.S. and International Patents Issued over Past Year REDWOOD CITY, CA / ACCESSWIRE / March 30, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and... 
From Avinger, Inc.
Via AccessWire
Topics Intellectual Property
Avinger Regains Compliance with Nasdaq Listing Requirements
REDWOOD CITY, CA / ACCESSWIRE / March 29, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Avinger Reports Fourth Quarter and Year End 2021 Results
REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,... 
From Avinger, Inc.
Via AccessWire
Avinger to Announce Full-Year 2021 Results on March 22
REDWOOD CITY, CA / ACCESSWIRE / March 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger to Effect One-for-Twenty Reverse Stock Split
REDWOOD CITY, CA / ACCESSWIRE / March 14, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.